Transgene Completes Safety and Tolerability Assessment of TG4001 in Combination with Avelumab in Phase 1b Part of Trial in HPV-Positive Cancer Patients - BioSpace

Transgene Completes Safety and Tolerability Assessment of TG4001 in Combination with Avelumab in Phase 1b Part of Trial in HPV-Positive Cancer Patients  BioSpace

STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (Paris:TNG), a biotechnology company that designs and develops virus-based ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2V1yhAM